CROI 2024 Report Back: Treatment Updates
Вставка
- Опубліковано 14 кві 2024
- Dr. Jehan Budak summarizes key study results from the CROI 2024 conference that focus on antiretroviral treatment, especially long-acting injectable cabotegravir/rilpivirine and lenacapavir.